Actor Portrayal
Actor Portrayal

Clinical Trial Results

WINREVAIR was studied in clinical trials called STELLAR and ZENITH.

Actor Portrayal

WINREVAIR was studied in a 6-month clinical trial called STELLAR.

  • 163 patients added WINREVAIR.
  • 160 patients added placebo.

Almost all patients in the trial (96%) were already taking 2 or 3 PAH medicines before adding WINREVAIR or placebo.

With WINREVAIR, you could improve your ability to exercise.

6-minute walk distance:

The image illustrates the change in 6-minute walk distance (6MWD) in patients with pulmonary arterial hypertension (PAH). A stopwatch icon labeled “6 MINS” represents the 6-minute walk distance test. The graphic compares the distance walked at the start of the study while patients were taking their current PAH medicines with the distance walked after adding WINREVAIR to current PAH medicines. The figure highlights an increase of 134 feet (41 meters) after 24 weeks
The image illustrates the change in 6-minute walk distance (6MWD) in patients with pulmonary arterial hypertension (PAH). A stopwatch icon labeled “6 MINS” represents the 6-minute walk distance test. The graphic compares the distance walked at the start of the study while patients were taking their current PAH medicines with the distance walked after adding WINREVAIR to current PAH medicines. The figure highlights an increase of 134 feet (41 meters) after 24 weeks
The image illustrates the change in 6-minute walk distance (6MWD) in patients with pulmonary arterial hypertension (PAH). A stopwatch icon labeled “6 MINS” represents the 6-minute walk distance test. The graphic compares the distance walked at the start of the study while patients were taking their current PAH medicines with the distance walked after adding WINREVAIR to current PAH medicines. The figure highlights an increase of 134 feet (41 meters) after 24 weeks
Actor Portrayal
Actor Portrayal

“We took the longer way home. 

That’s my win.”

WINREVAIR could keep your PAH from getting worse.

84% Lower Risk of Death or PAH Worsening84% Lower Risk of Death or PAH Worsening

What could your days be like if you had fewer PAH symptoms?

2x More WINREVAIR Patients Improved In Functional Class2x More WINREVAIR Patients Improved In Functional Class

Improvement in functional class means being physically active with fewer limitations from PAH symptoms, including:

Shortness of breath

Feeling tired

Feeling lightheaded

Chest pain

PVR and NT-proBNP are important measures of heart health and function that help your healthcare provider monitor your PAH.

PVR Is Defined as the Amount of Resistance to Blood Flow in the Lungs, Measured by a Right-Sided Heart Catheterization Test; NT-ProBNP Is a Protein That Helps Check for Stress on the Heart, Measured by a Blood TestPVR Is Defined as the Amount of Resistance to Blood Flow in the Lungs, Measured by a Right-Sided Heart Catheterization Test; NT-ProBNP Is a Protein That Helps Check for Stress on the Heart, Measured by a Blood Test

Your PAH care team may evaluate PVR and NT-proBNP along with other tests to get a more complete picture of your heart health and function.

Actor Portrayal

Actor Portrayal of Woman Kneeling on Floor and Petting Dog in Front of Closet. Text Reads, "What’s Your Win? Ask Your Healthcare Provider About the Possibilities for You With WINREVAIR."Actor Portrayal of Woman Kneeling on Floor and Petting Dog in Front of Closet. Text Reads, "What’s Your Win? Ask Your Healthcare Provider About the Possibilities for You With WINREVAIR."

Actor Portrayal

WINREVAIR was studied in a clinical trial called ZENITH.

  • 86 patients added WINREVAIR.
  • 86 patients added placebo.

All patients in the trial (100%) were already taking 2 or 3 PAH medicines before adding WINREVAIR or placebo. 

WINREVAIR could keep your PAH from getting worse.

76% Lower Risk of Hospitalization for PAH, Lung Transplant, or Death76% Lower Risk of Hospitalization for PAH, Lung Transplant, or Death
Actor Portrayal
Actor Portrayal

“I visited a new brunch spot. 

That’s my win.”

Actor Portrayal of Woman Sitting in Chair at Table With Food and Beverages. Text Reads, "What’s Your Win? Ask Your Healthcare Provider About the Possibilities for You With WINREVAIR."Actor Portrayal of Woman Sitting in Chair at Table With Food and Beverages. Text Reads, "What’s Your Win? Ask Your Healthcare Provider About the Possibilities for You With WINREVAIR."

What are the possible side effects of WINREVAIR?

How to take
WINREVAIR.

What is WINREVAIR?

WINREVAIR is a prescription medicine for adults with pulmonary arterial hypertension (PAH). PAH is a type of high blood pressure in the arteries of your lungs.

WINREVAIR can improve your ability to exercise and perform normal activities with fewer symptoms, and reduce the risk of your physical condition and symptoms worsening, including lowering your risk of hospitalization for PAH, lung transplant, and death.

Important Safety Information

Who should not take WINREVAIR?

  • Do not take WINREVAIR if you have had a serious allergic reaction to sotatercept-csrk or any of the other ingredients in WINREVAIR.

 

Before taking WINREVAIR and during treatment, tell your healthcare provider:

  • About all of your medical conditions and all of the medicines you take, including prescriptions and over-the-counter medicines, vitamins, or herbal supplements.
  • If you are pregnant, planning to get pregnant, become pregnant, or think you may be pregnant. If you are able to get pregnant, your healthcare provider should do a pregnancy test before you start taking WINREVAIR.
  • If you are breastfeeding or planning to breastfeed.

If you are able to get pregnant, you should use effective birth control during treatment with WINREVAIR and for at least 4 months after your final dose. WINREVAIR may harm your unborn baby. Do not breastfeed during treatment and for 4 months after your final dose.

 

WINREVAIR may cause serious side effects including:

  • Allergic (hypersensitivity) reactions. Allergic reactions, including anaphylaxis, can happen within hours or days after you use WINREVAIR. Call your healthcare provider or get medical help right away if you have any of these symptoms: hives, swelling of your face, lips, tongue or throat, sudden trouble breathing or swallowing. Before your next dose of WINREVAIR, tell your healthcare provider if you have had any symptoms of an allergic reaction.
  • High level of hemoglobin in your blood. Hemoglobin is a protein in red blood cells that carries oxygen. High levels of hemoglobin are common with WINREVAIR and can be severe and increase your risk for blood clots.
  • Severely low number of platelets in your blood. Platelets are blood cells that help blood clot. Low platelet counts are common with WINREVAIR and can be severe and increase your risk of bleeding. Tell your healthcare provider if you develop easy bruising or bleeding, bleeding that does not stop, or nosebleeds.
  • Serious bleeding. Serious bleeding can happen with WINREVAIR. Tell your healthcare provider if you develop any signs or symptoms of bleeding, including: vomiting blood or your vomit looks like coffee-grounds, pink or brown urine, red or black stools that look like tar, coughing up blood or blood clots, persistent headaches, nausea, dizziness or feeling weak, persistent abdominal cramps, severe back pain, or abnormally heavy menstrual bleeding.
  • Decreased fertility: WINREVAIR may affect female and male fertility, which may affect your ability to have children. Talk to your healthcare provider if this is a concern for you.

Your healthcare provider will do a blood test before your first 5 doses of WINREVAIR, longer if needed, and then from time to time to check your levels of hemoglobin and platelets.

 

The most common side effects of WINREVAIR include infections, headache, nosebleeds, rash, tiny blood vessels that look like pink or red lines on the skin (spider veins), diarrhea, dizziness, redness, and bleeding gums.

 

These are not all the possible side effects of WINREVAIR. Call your doctor for medical advice about side effects.

 

Taking WINREVAIR:

  • If your healthcare provider decides that you or a caregiver can give WINREVAIR at home, do not try to inject WINREVAIR until you or a caregiver have received training from your healthcare provider on the right way to prepare and inject the medicine.
  • Your healthcare provider may delay treatment or change your dose if needed, based on the results of your blood tests to check your hemoglobin and platelet levels.
  • See the detailed “Instructions for Use” booklet that comes with WINREVAIR for information on how to prepare and inject a dose of WINREVAIR.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

 

Please read the accompanying Patient Information and Instructions for Use (1-vial kit, 2-vial kit) for WINREVAIR, and discuss them with your doctor. The physician Prescribing Information also is available.

 

What is WINREVAIR?
Important Safety Information

WINREVAIR is a prescription medicine for adults with pulmonary arterial hypertension (PAH). PAH is a type of high blood pressure in the arteries of your lungs.

WINREVAIR can improve your ability to exercise and perform normal activities with fewer symptoms, and reduce the risk of your physical condition and symptoms worsening, including lowering your risk of hospitalization for PAH, lung transplant, and death.

Important Safety Information

Who should not take WINREVAIR?

  • Do not take WINREVAIR if you have had a serious allergic reaction to sotatercept-csrk or any of the other ingredients in WINREVAIR.

 

Before taking WINREVAIR and during treatment, tell your healthcare provider:

  • About all of your medical conditions and all of the medicines you take, including prescriptions and over-the-counter medicines, vitamins, or herbal supplements.
  • If you are pregnant, planning to get pregnant, become pregnant, or think you may be pregnant. If you are able to get pregnant, your healthcare provider should do a pregnancy test before you start taking WINREVAIR.
  • If you are breastfeeding or planning to breastfeed.

If you are able to get pregnant, you should use effective birth control during treatment with WINREVAIR and for at least 4 months after your final dose. WINREVAIR may harm your unborn baby. Do not breastfeed during treatment and for 4 months after your final dose.

 

WINREVAIR may cause serious side effects including:

  • Allergic (hypersensitivity) reactions. Allergic reactions, including anaphylaxis, can happen within hours or days after you use WINREVAIR. Call your healthcare provider or get medical help right away if you have any of these symptoms: hives, swelling of your face, lips, tongue or throat, sudden trouble breathing or swallowing. Before your next dose of WINREVAIR, tell your healthcare provider if you have had any symptoms of an allergic reaction.
  • High level of hemoglobin in your blood. Hemoglobin is a protein in red blood cells that carries oxygen. High levels of hemoglobin are common with WINREVAIR and can be severe and increase your risk for blood clots.
  • Severely low number of platelets in your blood. Platelets are blood cells that help blood clot. Low platelet counts are common with WINREVAIR and can be severe and increase your risk of bleeding. Tell your healthcare provider if you develop easy bruising or bleeding, bleeding that does not stop, or nosebleeds.
  • Serious bleeding. Serious bleeding can happen with WINREVAIR. Tell your healthcare provider if you develop any signs or symptoms of bleeding, including: vomiting blood or your vomit looks like coffee-grounds, pink or brown urine, red or black stools that look like tar, coughing up blood or blood clots, persistent headaches, nausea, dizziness or feeling weak, persistent abdominal cramps, severe back pain, or abnormally heavy menstrual bleeding.
  • Decreased fertility: WINREVAIR may affect female and male fertility, which may affect your ability to have children. Talk to your healthcare provider if this is a concern for you.

Your healthcare provider will do a blood test before your first 5 doses of WINREVAIR, longer if needed, and then from time to time to check your levels of hemoglobin and platelets.

 

The most common side effects of WINREVAIR include infections, headache, nosebleeds, rash, tiny blood vessels that look like pink or red lines on the skin (spider veins), diarrhea, dizziness, redness, and bleeding gums.

 

These are not all the possible side effects of WINREVAIR. Call your doctor for medical advice about side effects.

 

Taking WINREVAIR:

  • If your healthcare provider decides that you or a caregiver can give WINREVAIR at home, do not try to inject WINREVAIR until you or a caregiver have received training from your healthcare provider on the right way to prepare and inject the medicine.
  • Your healthcare provider may delay treatment or change your dose if needed, based on the results of your blood tests to check your hemoglobin and platelet levels.
  • See the detailed “Instructions for Use” booklet that comes with WINREVAIR for information on how to prepare and inject a dose of WINREVAIR.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

 

Please read the accompanying Patient Information and Instructions for Use (1-vial kit, 2-vial kit) for WINREVAIR, and discuss them with your doctor. The physician Prescribing Information also is available.